PT699103E - Membranas biocompativeis de superficie modificada - Google Patents

Membranas biocompativeis de superficie modificada

Info

Publication number
PT699103E
PT699103E PT94916437T PT94916437T PT699103E PT 699103 E PT699103 E PT 699103E PT 94916437 T PT94916437 T PT 94916437T PT 94916437 T PT94916437 T PT 94916437T PT 699103 E PT699103 E PT 699103E
Authority
PT
Portugal
Prior art keywords
pct
biocompatible membranes
modified surface
sec
date
Prior art date
Application number
PT94916437T
Other languages
English (en)
Inventor
Elisabeth Scholander
Andrzej Werynski
Andrzej Jozwlak
Olle Larm
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of PT699103E publication Critical patent/PT699103E/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0081—After-treatment of organic or inorganic membranes
    • B01D67/0093—Chemical modification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0011—Casting solutions therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0016—Coagulation
    • B01D67/00165—Composition of the coagulation baths
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/08—Specific temperatures applied
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/12—Specific ratios of components used

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Reciprocating, Oscillating Or Vibrating Motors (AREA)
PT94916437T 1993-05-19 1994-05-09 Membranas biocompativeis de superficie modificada PT699103E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO931809A NO931809L (no) 1993-05-19 1993-05-19 Hemofilter

Publications (1)

Publication Number Publication Date
PT699103E true PT699103E (pt) 2004-04-30

Family

ID=19896100

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94916437T PT699103E (pt) 1993-05-19 1994-05-09 Membranas biocompativeis de superficie modificada

Country Status (14)

Country Link
US (1) US5840190A (pt)
EP (1) EP0699103B1 (pt)
JP (1) JPH08510166A (pt)
AT (1) ATE254953T1 (pt)
AU (1) AU672708B2 (pt)
BR (1) BR9406410A (pt)
CA (1) CA2162495A1 (pt)
DE (1) DE69433356T2 (pt)
DK (1) DK0699103T3 (pt)
ES (1) ES2211881T3 (pt)
FI (1) FI955525A7 (pt)
NO (1) NO931809L (pt)
PT (1) PT699103E (pt)
WO (1) WO1994026399A1 (pt)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304220A (en) * 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
US20020156523A1 (en) * 1994-08-31 2002-10-24 Lilip Lau Exterior supported self-expanding stent-graft
US6331188B1 (en) * 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
DE19514104C2 (de) * 1995-04-13 1997-05-28 Behringwerke Ag Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial
BR9709867A (pt) * 1996-06-20 2000-01-11 Sulzer Vascutek Ltda Dispositivo para a retenção uma prótese em uma passagrm do corpo dispositivo para a fixação de uma prótese em uma superfìcie interna de uma passagem do corpo, dispositivo protético, prótese e processo para fixar um dispositivo protético, para reparar um vaso e para inserir uma prótese em uma passagem do corpo.
US6551350B1 (en) * 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
FR2772639B1 (fr) 1997-12-24 2000-02-04 Hospal Ind Utilisation d'un polymere neutre ou cationique pour prevenir l'activation de la phase contact du sang ou du plasma en contact avec une membrane semi-permeable
US6221425B1 (en) * 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
KR20010020807A (ko) 1999-05-03 2001-03-15 조셉 제이. 스위니 고정 연마재 제품을 사전-조절하는 방법
FR2804328B1 (fr) * 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
US7374644B2 (en) 2000-02-17 2008-05-20 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
US6991528B2 (en) 2000-02-17 2006-01-31 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
US7678245B2 (en) 2000-02-17 2010-03-16 Applied Materials, Inc. Method and apparatus for electrochemical mechanical processing
US7077721B2 (en) 2000-02-17 2006-07-18 Applied Materials, Inc. Pad assembly for electrochemical mechanical processing
US7059948B2 (en) 2000-12-22 2006-06-13 Applied Materials Articles for polishing semiconductor substrates
US7125477B2 (en) 2000-02-17 2006-10-24 Applied Materials, Inc. Contacts for electrochemical processing
US7670468B2 (en) 2000-02-17 2010-03-02 Applied Materials, Inc. Contact assembly and method for electrochemical mechanical processing
US7029365B2 (en) * 2000-02-17 2006-04-18 Applied Materials Inc. Pad assembly for electrochemical mechanical processing
US6962524B2 (en) 2000-02-17 2005-11-08 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
US7066800B2 (en) 2000-02-17 2006-06-27 Applied Materials Inc. Conductive polishing article for electrochemical mechanical polishing
US7303462B2 (en) 2000-02-17 2007-12-04 Applied Materials, Inc. Edge bead removal by an electro polishing process
US6848970B2 (en) 2002-09-16 2005-02-01 Applied Materials, Inc. Process control in electrochemically assisted planarization
US7303662B2 (en) 2000-02-17 2007-12-04 Applied Materials, Inc. Contacts for electrochemical processing
US7344432B2 (en) 2001-04-24 2008-03-18 Applied Materials, Inc. Conductive pad with ion exchange membrane for electrochemical mechanical polishing
US7137879B2 (en) 2001-04-24 2006-11-21 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
US7297553B2 (en) 2002-05-28 2007-11-20 Nanosphere, Inc. Method for attachment of silylated molecules to glass surfaces
AU2005241112B2 (en) * 2001-07-13 2009-07-30 Nanosphere, Inc. Method for preparing substrates having immobilized molecules and substrates
WO2003006676A2 (en) 2001-07-13 2003-01-23 Nanosphere, Inc. Method for immobilizing molecules onto surfaces
US7407668B2 (en) * 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
SE527054C2 (sv) * 2002-04-23 2005-12-13 Gambro Lundia Ab Förfarande för framställning av ett regioselektivt membran
DE102004008219B3 (de) * 2004-02-19 2005-10-27 Membrana Gmbh Integral asymmetrische Membran, Verfahren zu ihrer Herstellung und ihre Verwendung
US7520968B2 (en) 2004-10-05 2009-04-21 Applied Materials, Inc. Conductive pad design modification for better wafer-pad contact
WO2006049160A1 (ja) * 2004-11-05 2006-05-11 Kaneka Corporation 血液接触材料の改質方法、及び顆粒球活性化が抑制された血液接触材料
US7427340B2 (en) 2005-04-08 2008-09-23 Applied Materials, Inc. Conductive pad
DK1960016T3 (en) 2005-12-13 2017-01-09 Exthera Medical Corp Method for extracorporeal removal by a pathogenic MI-KROBE, an inflammatory cell or inflammatory protein from the blood.
US20080135481A1 (en) * 2006-12-06 2008-06-12 General Electric Company Polyarylethernitrile hollow fiber membranes
US7977451B2 (en) * 2006-12-15 2011-07-12 General Electric Company Polyarylether membranes
US7681741B2 (en) * 2006-12-15 2010-03-23 General Electric Company Functional polyarylethers
US20110168631A1 (en) * 2006-12-15 2011-07-14 General Electric Company Methods and apparatuses for water filtration using polyarylether membranes
US7669720B2 (en) * 2006-12-15 2010-03-02 General Electric Company Functional polyarylethers
AU2008265838A1 (en) * 2007-06-18 2008-12-24 Exthera Medical Llc Device and method for restoration of the condition of blood
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
CN100548456C (zh) * 2007-08-29 2009-10-14 浙江大学 一种亲和性丙烯腈基共聚物超细纤维膜的制备方法和应用
US20090069790A1 (en) * 2007-09-07 2009-03-12 Edward Maxwell Yokley Surface properties of polymeric materials with nanoscale functional coating
US8962097B1 (en) 2007-09-07 2015-02-24 Edward Maxwell Yokley Surface properties of polymeric materials with nanoscale functional coating
DE102008000220A1 (de) * 2008-02-01 2009-08-13 ASCALON Gesellschaft für Innovation in der Medizintechnik m.b.H. Hohlfaser-Separationsmembranen und Verfahren zu ihrer Herstellung
US20100222489A1 (en) * 2009-02-27 2010-09-02 Jiang Dayue D Copolymer composition, membrane article, and methods thereof
EP2509604B1 (en) 2009-12-01 2021-03-17 ExThera Medical Corporation Device for removing cytokines from blood with surface immobilized polysaccharides
FR2960783B1 (fr) 2010-06-04 2012-07-27 Ass Pour Les Transferts De Technologies Du Mans Membrane fonctionnalisee pour chambre d'encapsulation de cellules produisant au moins une substance d'interet therapeutique et organe bioartificiel comprenant une telle membrane
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
MX376935B (es) 2013-06-24 2025-03-07 Exthera Medical Corp Sistema de filtración de sangre que contiene substrato recubierto con manosa.
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
CN105813626B (zh) * 2013-12-09 2019-05-07 株式会社Lg生活健康 含有碳二亚胺类化合物的组合物
AU2015250107A1 (en) 2014-04-24 2016-11-17 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
EP3680005A1 (en) * 2019-01-10 2020-07-15 Gambro Lundia AB Membrane with immobilized anticoagulant and process for producing same
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
EP3981505B1 (en) 2020-10-12 2024-11-27 Gambro Lundia AB Membrane with immobilized anticoagulant and process for producing same
KR20230146015A (ko) * 2021-02-12 2023-10-18 솔베이 스페셜티 폴리머즈 유에스에이, 엘.엘.씨. 설폰 중합체 상에의 생물활성 화합물 고정화
CN115120787B (zh) * 2022-06-30 2023-06-23 上海翊科聚合物科技有限公司 一种血液透析复合膜制备方法及应用
CN116789966B (zh) * 2023-06-21 2025-09-12 明基生物技术(上海)有限公司 改性聚砜与中空纤维膜及其制备方法
EP4497494A1 (en) * 2023-07-24 2025-01-29 Gambro Lundia AB Sma-blended membranes for immobilizing functional molecules
CN118718155B (zh) * 2024-09-03 2025-01-17 延阳康科技服务(上海)有限公司 一种血浆吸附过滤器和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441142A (en) * 1966-07-21 1969-04-29 Dow Chemical Co Nonthrombogenic plastic membranes
US3522346A (en) * 1968-05-31 1970-07-28 Research Corp Nonthrombogenic microcapsules
US3616935A (en) * 1970-02-05 1971-11-02 Dow Chemical Co Preparation of antithrombogenic surfaces
US3705084A (en) * 1970-03-18 1972-12-05 Monsanto Co Macroporous enzyme reactor
US4102746A (en) * 1975-08-29 1978-07-25 Amerace Corporation Immobilized proteins
US4702840A (en) * 1982-02-05 1987-10-27 Pall Corporation Charge modified polyamide membrane
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4906375A (en) * 1984-07-14 1990-03-06 Fresenius, Ag Asymmetrical microporous hollow fiber for hemodialysis
US4757014A (en) * 1985-11-08 1988-07-12 Minnesota Mining And Manufacturing Company Immobilization of biologically active protein on a polymeric fibrous support
GB8915974D0 (en) * 1989-07-12 1989-08-31 Gore W L & Ass Uk Hydrophilic semi-permeable ptfe membranes and their manufacture
US5096585A (en) * 1991-01-28 1992-03-17 W. R. Grace & Co.-Conn. Process for preparing protein non-adsorptive microporous polysulfone membranes
US5283186A (en) * 1991-12-31 1994-02-01 Abbott Laboratories Preparation of a compressed membrane containing immobilized biologically acting material
DE4238389A1 (de) * 1992-11-13 1994-05-19 Bayer Ag Verfahren zur Durchführung immundiagnostischer Nachweise
US5476665A (en) * 1994-04-13 1995-12-19 Minnesota Mining And Manufacturing Company Azlactone functional particles incorporated in a membrane formed by solvent phase inversion

Also Published As

Publication number Publication date
JPH08510166A (ja) 1996-10-29
NO931809L (no) 1994-11-21
AU672708B2 (en) 1996-10-10
NO931809D0 (no) 1993-05-19
ES2211881T3 (es) 2004-07-16
AU6816994A (en) 1994-12-12
DK0699103T3 (da) 2004-04-05
FI955525A0 (fi) 1995-11-16
CA2162495A1 (en) 1994-11-24
FI955525L (fi) 1995-11-16
US5840190A (en) 1998-11-24
ATE254953T1 (de) 2003-12-15
WO1994026399A1 (en) 1994-11-24
FI955525A7 (fi) 1995-11-16
BR9406410A (pt) 1995-12-19
DE69433356D1 (de) 2004-01-08
DE69433356T2 (de) 2004-08-26
EP0699103B1 (en) 2003-11-26
EP0699103A1 (en) 1996-03-06

Similar Documents

Publication Publication Date Title
PT699103E (pt) Membranas biocompativeis de superficie modificada
AU3506893A (en) Use of fullerenes in diagnostic and/or therapeutic agents
IL117697A (en) Polysiloxane-comprising perfluoroalkyl ethers, and the preparation and use thereof
DK1028707T3 (da) Oftalmiske præparater med forlænget frigivelse og indeholdende vandopløselige medikamenter
GB2289637B (en) Flexible elastomeric article with enhanced lubricity
MX9704828A (es) Una pelicula encogible en agua.
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
ATE173171T1 (de) Gerät und methode für den lokalen auftrag von polymermaterial auf gewebe
NO984100L (no) Absorberende gjenstand med redusert toppsjiktvedhefting
GEP20032976B (en) Artificial Peptides Having Surface Activity and Use Thereof in The Preparation of Artificial Surfactant
GR3030858T3 (en) Item of clothing, especially disposable clothing for use once only
ATE211636T1 (de) Methode zum herstellen eines dentalproduktes
EP0525795A3 (en) Use of fluorinated polyurethanes for the treatment of films or sheets made of cellulose, graphite, mica, kaolin, leather and similar natural materials
ZA981780B (en) The use of levobupivacaine in paediatric surgery
DE59610633D1 (de) Medikament, insbesondere zur modulation der immunantwort bei der bekämpfung von viren, tumoren, bakterien und parasiten
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
GB9411009D0 (en) Dialysis fluid
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE69930419D1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
DE69700785D1 (de) Hypodermische kanüle aus weichem material
DE69319140D1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
NO984965L (no) Komponent B som cicatrisant
SE9403861D0 (sv) Novel medicinal use